Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Total Debt (2023 - 2024)

Tonix Pharmaceuticals Holding (TNXP) has 2 years of Total Debt data on record, last reported at $7.5 million in Q4 2024.

  • For Q4 2024, Total Debt fell 15.98% year-over-year to $7.5 million; the TTM value through Dec 2024 reached $7.5 million, down 15.98%, while the annual FY2024 figure was $7.5 million, 15.98% down from the prior year.
  • Total Debt reached $7.5 million in Q4 2024 per TNXP's latest filing, down from $8.0 million in the prior quarter.
  • Across five years, Total Debt topped out at $9.0 million in Q1 2024 and bottomed at $7.5 million in Q4 2024.